Bacteroides dorei BDX-01 alleviates DSS-induced experimental colitis in mice by regulating intestinal bile salt hydrolase activity and the FXR-NLRP3 signaling pathway
Conclusion: BDX-01 improved DSS-induced acute colitis by regulating intestinal BSH activity and the FXR-NLRP3 signaling pathway. Our findings indicate that BDX-01 is a promising probiotic to improve the management of ulcerative colitis.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Bacteroides Infection | Bile | Drugs & Pharmacology | Genetics | Inflammatory Bowel Disease | Probiotics | Sodium | Sodium Chloride | Study | Ulcerative Colitis